Race to save ventilator patients: inhaled drug fights deadly viruses
Disease control
Recruiting now
This study is testing an inhaled drug called SNG001 for patients who are critically ill with viral pneumonia and on a breathing machine (ventilator). The goal is to see if the drug is safe and if it can help the body clear the virus faster, reduce time on the ventilator, and lowe…
Phase: PHASE2 • Sponsor: Synairgen Research Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC